We believe in a more human approach to investing, both in and out of the office. That’s why we’ve built a firm that prizes the intrinsic value of the work and the people who work here, over the formalities and pretenses of the corporate world…
Headquartered in Grand Rapids, Michigan, Infusion Associates (“IA”) is a leading provider of clinically-supervised ambulatory infusion services, with 13 wholly-owned locations across Michigan, Minnesota, and Ohio. IA administers more than 50,000 infusion treatments annually, with a focus on complex biologic therapies treating chronic conditions such as Crohn’s, multiple sclerosis, and arthritic conditions. IA’s specialized team of clinicians manage patient care on a long-term basis and administer treatments on behalf of more than 2,200 referring specialists across a range of clinical specialties including rheumatology, gastroenterology, and neurology, among others.
In November of 2018, IA partnered with Boyne Capital, a Miami, FL-based Private Equity firm that seeks to forge lasting and collaborative relationships with companies and support them in achieving their next phase of growth. Since then, the business has scaled from 1 location to 13, with continuing year-over-year growth from organic initiatives, and completed 6 strategic acquisitions.
Reporting to the COO, the Director of Business Development is a key partner to the executive leadership team in the execution of the company’s strategic growth plans in Wisconsin and Minnesota and achievement of financial goals. The Director of Business Development will provide leadership for the company’s Wisconsin and Minnesota M&A and de novo strategy and operations with an emphasis on identification and integration of add-on acquisitions and successful de novo launches. The ideal candidate has participated in M&A and de novo growth for a business involving office or clinic based multi-site / multi-state healthcare services in Wisconsin and/or Minnesota.
COMPENSATION & BENEFITS